Kiniksa Pharmaceuticals Ltd reports results for the quarter ended in March - Earnings Summary

Kiniksa Pharmaceuticals International

04/05/2021 18:16

* Kiniksa Pharmaceuticals Ltd  KNSA.OQ  reported a quarterly
adjusted loss of 72 cents​​ per share for the quarter ended
in March. The mean expectation of four analysts for the quarter
was for a loss of 72 cents per share.
* Revenue was $0.00​​;  analysts expected $7.78 million.
* Kiniksa Pharmaceuticals Ltd's reported EPS for the quarter was
a loss of 72 cents​.
* The mean earnings estimate of analysts had fallen by
about 6.1% in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates and  
* Kiniksa Pharmaceuticals Ltd shares had fallen by 10.8% this
quarter and lost 6.5% so far this year.
* The company reported a quarterly loss of $49.48 million.
* Wall Street's median 12-month price target for Kiniksa
Pharmaceuticals Ltd is $34.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 4 at 05:16 p.m. GMT. ​All
figures in US Dollars.​